Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001628280-17-003762
Filing Date
2017-04-18
Accepted
2017-04-18 16:01:22
Documents
5
Period of Report
2016-12-31
Effectiveness Date
2017-04-18

Document Format Files

Seq Description Document Type Size
1 DEF 14A adms2017proxystatement.htm DEF 14A 503347
2 admssignature.jpg GRAPHIC 19006
3 pc1.jpg GRAPHIC 78032
4 pc2.jpg GRAPHIC 74195
5 proxyadmslogo.jpg GRAPHIC 3700
  Complete submission text file 0001628280-17-003762.txt   734894
Mailing Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Filer) CIK: 0001328143 (see all company filings)

EIN.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36399 | Film No.: 17767036
SIC: 2834 Pharmaceutical Preparations